|
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison |
|
|
|
Titel: |
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison |
Auteur: |
Santoni, Matteo Aurilio, Gaetano Massari, Francesco Grande, Enrique Matrana, Marc R Rizzo, Mimma De Giorgi, Ugo Incorvaia, Lorena Martignetti, Angelo Molina-Cerrillo, Javier Zabalza, Ignacio Ortego Mollica, Veronica Rizzo, Alessandro Battelli, Nicola Porta, Camillo |
Verschenen in: |
Clinical genitourinary cancer |
Paginering: |
Jaargang 20 () nr. 3 pagina's 285-295 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|